Učitavanje...
Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction
Myocardial infarction (MI) is one of the leading causes of death worldwide. Mesenchymal stem cell (MSC) transplantation is considered a promising approach and has made significant progress in preclinical studies and clinical trials for treating MI. However, hurdles including poor survival, retention...
Spremljeno u:
| Izdano u: | Stem Cells Int |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6286742/ https://ncbi.nlm.nih.gov/pubmed/30622568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7045245 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|